Cargando…

Su1187 ALMOST EVERYTHING CAUSES DIARRHEA: GASTROINTESTINAL MANIFESTATIONS OF ACUTE RESPIRATORY INFECTIONS AMONG 3,510 INDIVIDUALS IN A COMMUNITY-BASED STUDY

Detalles Bibliográficos
Autores principales:	Newman, Kira L., Brandstetter, Elisabeth, Wolf, Caitlin, Logue, Jennifer, Engund, Janet A., Boeckh, Michael, Chu, Helen Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AGA Institute. Published by Elsevier Inc. 2020
Materias:	AGA Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237182/ http://dx.doi.org/10.1016/S0016-5085(20)32035-7

Ejemplares similares

Fr095 AN ANALYSIS OF GI AND NON-GI MANIFESTATIONS OF COVID-19 DURING THE FIRST WAVE OF THE PANDEMIC IN DARLINGTON, UNITED KINGDOM
por: Dhar, Anjan, et al.
Publicado: (2021)

Nausea, Vomiting, and Diarrhea Are Common in Community-Acquired Acute Viral Respiratory Illness
por: Newman, Kira L., et al.
Publicado: (2023)

Su1094: HOSPITILISATIONS FOR NOROVIRUS DECREASE DURING THE COVID-19 PANDEMIC
por: Gottlieb, Max T., et al.
Publicado: (2022)

Sa1273: ENTERIC NEURONAL VASOACTIVE INTESTINAL PEPTIDE MEDIATES SARS-COV-2 ASSOCIATED DIARRHEA
por: Balasubramaniam, Arun, et al.
Publicado: (2022)

Su1076: DIVERTICULOSIS IS ASSOCIATED WITH INTERNAL HEMORRHOIDS ON COLONOSCOPY: POSSIBLE CLUES TO ETIOLOGY.
por: Sninsky, Jared A., et al.
Publicado: (2022)

Fr578 ORAL TANNINS REDUCE PROINFLAMMATORY CYTOKINES ASSOCIATED WITH DIARRHEA AND PNEUMONIA IN HOSPITALIZED COVID-19 PATIENTS.
por: Pisarevsky, Ana A., et al.
Publicado: (2021)

Sa1275: ASSOCIATED FACTORS WITH ACUTE DIARRHEA IN SARS-COV-2 INFECTION: A CASE-CONTROL STUDY
por: Tellez, Francisco A. Felix, et al.
Publicado: (2022)

Su083 PERSISTENCE OF GASTROINTESTINAL SYMPTOMS AFTER HOSPITALIZATION FOR COVID-19: PREVALENCE AND RISK FACTORS
por: Blackett, John W., et al.
Publicado: (2021)

Su1495: COVID-19 VACCINE HESITANCY REMAINS HIGH IN INFLAMMATORY BOWEL DISEASE PATIENTS
por: Kwon, Hyuk Joon, et al.
Publicado: (2022)

Su1491: ATTITUDES AND PREDICTORS OF COVID-19 VACCINE UPTAKE IN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE
por: Zhang, Eva, et al.
Publicado: (2022)

Su1482: SCOUT IBD: SURVEILLANCE OF COVID-19 IMPACT ON LONG-TERM OUTCOMES IN IBD
por: Hong, Simon J., et al.
Publicado: (2022)

Su1498: SAFETY OF COVID-19 VACCINATION IN INFLAMMATORY BOWEL DISEASE PATIENTS ON BIOLOGIC THERAPY
por: Garrido, Isabel, et al.
Publicado: (2022)

Su1000: IMPACT OF COVID-19 PANDEMIC AND SOCIAL DETERMINANTS OF HEALTH ON UTILIZATION OF TELEHEALTH SERVICES
por: Sanaka, Harsha, et al.
Publicado: (2022)

Fr003 TRUE PREVALENCE OF SARS-COV-2 INDUCED DIARRHEA AMONG YOUNG AND OLDER ADULTS: A MULTICENTER STUDY
por: Perisetti, Abhilash, et al.
Publicado: (2021)

Sa1000: DIARRHEA, ELEVATED AST, AND ELEVATION OF INFLAMMATORYRELATED BIOMARKERS IS A PREDICTOR FOR MORTALITY IN MINORITY HOSPITALISED COVID-19 PATIENTS
por: Ashktorab, Hassan, et al.
Publicado: (2022)

Su1189 SAFETY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH PREEXISTING INFLAMMATORY BOWEL DISEASE AND MICROSCOPIC COLITIS
por: Grover, Shilpa, et al.
Publicado: (2020)

Su1500: COMPARATIVE EFFICACY AND SAFETY OF OZANIMOD AND USTEKINUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
por: Dubinsky, Marla C., et al.
Publicado: (2022)

Su1270: CHRONIC PANCREATITIS AND COVID-19: INCIDENCE AND OUTCOMES. A MULTICENTER RESEARCH NETWORK ANALYSIS
por: Hadi, Yousaf, et al.
Publicado: (2022)

Su1003: IMPACT OF THE COVID-19 PANDEMIC ON HEALTHCARE ACCESS, DELIVERY AND VACCINATION IN PATIENTS WITH DIGESTIVE DISORDERS
por: Russin, Michelle, et al.
Publicado: (2022)

Fr492 SIGNIFICANTLY REDUCED MORTALITY IN COVID-19 PATIENTS WITH GASTROINTESTINAL MANIFESTATIONS
por: Livanos, Alexandra E., et al.
Publicado: (2021)

Su094 IMMUNE AND METABOLIC PATHOGENESIS OF ENVIRONMENTAL ENTERIC DYSFUNCTION IN CHILDHOOD UNDERNUTRITION: A BIRTH INCEPTION COHORT
por: Haberman, Yael, et al.
Publicado: (2021)

Su1487: IMPACT OF INFLAMMATORY BOWEL DISEASE THERAPIES ON DURABILITY OF HUMORAL RESPONSE TO SARS COV-2 VACCINATION
por: Charilaou, Paris, et al.
Publicado: (2022)

Su1496: SARS-COV-2 INFECTION IN IBD: PANDEMIC WAVES AND PREDICTORS OF SEVERE OR PERSISTENT COVID-19
por: Taxonera, Carlos, et al.
Publicado: (2022)

Su1483: COVID-19 VACCINES ARE HIGHLY EFFECTIVE IN PATIENTS WITH IBD: OUTCOMES FROM THE SCOUT IBD COHORT
por: Hong, Simon J., et al.
Publicado: (2022)

Su1480: TREATMENT-EMERGENT COVID-19 INFECTIONS IN OZANIMOD ULCERATIVE COLITIS AND MULTIPLE SCLEROSIS CLINICAL TRIALS
por: Ungaro, Ryan C., et al.
Publicado: (2022)

Su1067: LIVER ENZYMES ALTERATION BUT NOT GI SYMPTOMS ARE ASSOCIATED WITH DEATH IN MINORITY COVID-19 PATIENTS WITH CANCER
por: Oskrochi, Gholamreza, et al.
Publicado: (2022)

Su102 DIFFERENCES IN INTESTINAL EPITHELIAL GENE EXPRESSION MODULATES SARS-COV-2 INFECTION IN HUMAN IBD ENTEROIDS
por: Alvarado, David M., et al.
Publicado: (2021)

Su1489: HUMORAL IMMUNOGENICITY OF THREE SARS-COV-2 MRNA VACCINE DOSES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Schell, Trevor, et al.
Publicado: (2022)

Su1501: PROPHYLACTIC VERSUS ENDOSCOPY DRIVEN TREATMENT OF CROHN'S POSTOPERATIVE RECURRENCE: A RETROSPECTIVE MULTICENTRIC EUROPEAN STUDY
por: Geldof, Jeroen, et al.
Publicado: (2022)

Su1497: EFFECT OF SARS COV-2 VACCINE IN IBD PATIENTS ON BIOLOGIC THERAPY INCLUDING LIVER TRANSPLANT RECIPIENTS.
por: Brezina, Jan, et al.
Publicado: (2022)

Su1075: SIMILAR RISK OF INFECTION WITH SARS-COV-2 IN IMMUNOCOMPROMISED AND IMMUNOCOMPETENT PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND HEALTHY CONTROLS
por: Kante, Bhaskar, et al.
Publicado: (2022)

Su1065: INCREASED INTEREST IN WEIGHT LOSS AND BARIATRIC INTERVENTIONS DURING THE COVID-19 PANDEMIC: AN ANALYSIS OF INTERNET SEARCH QUERIES
por: Rajan, Anjana, et al.
Publicado: (2022)

Su1484: SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
por: Quan, Joshua, et al.
Publicado: (2022)

Su1005: PRE-ENDOSCOPY CONSULTATION AND ADHERENCE TO OUTPATIENT ENDOSCOPY DURING COVID-19 PANDEMIC: IN-PERSON VISIT VERSUS TELEHEALTH
por: Musa, Abdullahi, et al.
Publicado: (2022)

Fr134 SARS-COV-2 INDUCES EPITHYELIAL-NEURONAL CROSSTALK STIMULATING VASOACTIVE INTESTINAL PEPTIDE RELEASE AS A POTENTIAL MECHANISM OF COVID-19-ASSOCIATED DIARRHEA
por: He, Peijian, et al.
Publicado: (2021)

Su093 GUT-BRAIN AXIS AND IRRITABLE BOWEL SYNDROME DURING SARS COV-2 PANDEMIC. A SURVEY BASED STUDY.
por: Piskorz, Maria, et al.
Publicado: (2021)

Su254 REDUCED ENDOSCOPY UTILIZATION FOR UPPER GASTROINTESTINAL BLEEDING DURING COVID-19 PANDEMIC: A MULTICENTER RESEARCH NETWORK STUDY
por: Goyal, Hemant, et al.
Publicado: (2021)

Su089 SATISFACTION WITH TELEHEALTH AMONG PATIENTS WITH IBS DURING COVID-19: INITIAL FINDINGS FROM A CROSS-SECTIONAL SURVEY
por: Yu, Christine, et al.
Publicado: (2021)

Su1493: COVID-19 RELATED THROMBOTIC, CARDIOVASCULAR, AND RENAL COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM AN INTERNATIONAL REGISTRY
por: Spiera, Emily, et al.
Publicado: (2022)

Su1485: COVID-19 VACCINE-INDUCED ANTIBODY RESPONSES ARE IMPAIRED IN IBD PATIENTS TREATED WITH INFLIXIMAB, USTEKINUMAB OR TOFACITINIB, BUT NOT THIOPURINES OR VEDOLIZUMAB
por: Alexander, James L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_thgtqv794a4iar5po2kjhbof4q